| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |